Skip to content

Clinical trials

Phase 2/3 Diabetes Mellitus, Type 2 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2/3 Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20066
20073
20086
20093
20103
20122
20151
20201
20211
20221
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting2
Terminated2
Withdrawn2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Nutrition3
AstraZeneca3
Joslin Diabetes Center2
Novartis2
VA Office of Research and Development2
AtheroGenics1
Brigham and Women's Hospital1
Daiichi Sankyo1
DiObex1
Durham VA Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 233
Diabetes Mellitus8
Obesity6
Diabetes Mellitus, Type 13
Inflammation3
Albuminuria2
Insulin Resistance2
Metabolic Syndrome2
Atherosclerosis1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.